Jiangxi Synergy Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GABAPENTIN, with a corresponding US DMF Number 25825.
Remarkably, this DMF maintains an Active status since its submission on February 22, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 06, 2013, and payment made on November 27, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II